“I am honored to join SwedenBio’s board and look forward to strengthening Sweden’s life science industry, supporting our innovative companies to thrive,” says Hanna Sjöström, CEO of Neola Medical

Hanna Sjöström’s appointment strengthens the voice of MedTech within SwedenBIO and reflects her continued engagement in advancing Sweden’s position in life science innovation, commercialization, and international growth.

Sjöström has previously been profiled for her role in SwedenBIO’s expert network, where she leads the Medtech Working Group, a forum focused on key strategic issues such as market access, regulatory alignment, and internationalization.

Read more about her role in the expert network here: CEO Hanna Sjöström Chairman for MedTech in SwedenBIO’s new expert network

In SwedenBIO’s latest annual report, Hanna Sjöström shares her perspective on the current landscape for MedTech companies, including the opportunities and challenges facing innovative life science businesses with global ambitions.

Read the full interview with Hanna Sjöström in SwedenBIO’s Annual Report: SwedenBIO Annual Report 2024

About SwedenBIO
SwedenBIO is the national industry organization for life sciences in Sweden. Member companies within SwedenBIO primarily focus on the development of biotechnology, diagnostics, pharmaceuticals, and medical technology, or they specialize in areas such as business development, intellectual property, and legal matters. SwedenBIO also brings together financiers, incubators, science parks, regional investment promotion actors, and many more. A common characteristic among all members is their contribution to the advancement of medical innovations that enhance people's health in Sweden and around the world. Founded in 2002, SwedenBIO is a non-profit membership organization.